MedTrace Logo

Human Skin Safety Testing of a Mitopure Topical Product Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers

NCT05079607 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2021-11-23

No results posted yet for this study

Summary

The objective of this study is to investigate the irritation and sensitization potential of multiple topically applied test articles (containing different concentrations of Mitopure), in a shared panel of healthy volunteers by means of repeated cutaneous patch applications under occlusion based on the modified Draize method

Conditions

  • Irritation/Irritant
  • Sensitisation

Interventions

OTHER

Mitopure Topical Formula 1

topical skin cream containing the low dose mitophagy activator Mitopure

OTHER

Mitopure Topical Formula 2

topical skin cream containing the high dose mitophagy activator Mitopure

Sponsors & Collaborators

  • Princeton Research Corporation

    collaborator UNKNOWN

  • Amazentis SA

    lead INDUSTRY

Principal Investigators

  • Anurag Singh, MD, PhD · Amazentis SA

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-04
Primary Completion
2021-11-15
Completion
2021-11-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05079607 on ClinicalTrials.gov